Appili Therapeutics (OTCMKTS:APLIF – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01), Yahoo Finance reports.
Appili Therapeutics Stock Performance
Shares of APLIF stock remained flat at $0.02 during trading on Wednesday. The stock has a market capitalization of $2.92 million, a P/E ratio of -0.80 and a beta of -0.49. The stock has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.03. Appili Therapeutics has a 12 month low of $0.02 and a 12 month high of $0.07.
Appili Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Appili Therapeutics
- How to Invest in Blue Chip Stocks
- Serve Robotics Is Serving Up a Selling Opportunity
- How to Calculate Stock Profit
- Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Microsoft Stock: Is Now The Time To Be Greedy?
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.